Please use this identifier to cite or link to this item:
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Complementary and alternative medicine use in patients with haematological malignancies in Europe
Authors: Molassiotis, Alexander
Margulies, Anita
Fernandez-Ortega, Paz
Pud, Dorit
Panteli, Vassiliki
Bruyns, Ingrid
Scott, Julia
Gudmundsdottir, Gudbjorg
Browall, Maria
Madsen, Elin
Ozden, Gulten
Magri, Miriam
Selvekerova, Sarka
Platin, Nurgun
Kearney, Nora
Patiraki, Elisabeth
Contact Email:
Keywords: Haematologic cancers
Issue Date: May-2005
Publisher: Elsevier
Citation: Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott J, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N & Patiraki E (2005) Complementary and alternative medicine use in patients with haematological malignancies in Europe, Complementary Therapies in Clinical Practice, 11 (2), pp. 105-110.
Abstract: Summary This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional wellbeing. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.
Type: Journal Article
DOI Link:
Rights: The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.
Affiliation: University of Manchester
University Hospital Zurich
Institut CatalĂ  Oncologia ICO
University of Haifa
Greek Oncology Nursing Society
Belgian Society of Oncology Nursing
HS UG Regulated - Stirling
Department of Oncology, Landspitali
Sahlgrenska University Hospital, Sweden
Aarhus University Hospital
Gazi University Hospital
University of Milan
Masaryk Memorial Cancer Institute
Koc University
Cancer Care Research Centre
Greek Oncology Nursing Society

Files in This Item:
File Description SizeFormat 
Molassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdf178.88 kBAdobe PDFUnder Embargo until 31/12/2999     Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependant on the depositor still being contactable at their original email address.

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.